Specifically, we test two hypotheses: (1) the volume of medical services for prostate and thyroid cancer patients increases following the adoption of robotic surgery, and (2) the volume of prostate-specific antigen (PSA) tests increases after robotic surgery adoption. Here, KLK3 is linked to thyroid gland carcinoma.